Speeding Up Drug Discovery

Adimab
Lebanon, N.H.
Human antibody discovery
Co-founder and CEO: Tillman Gerngross

Led by two of the world's leading yeast biotechnologists, Dartmouth's Tillman Gerngross and the Massachusetts Institute of Technology's Dane Wittrup, Adimab has built a yeast-based antibody discovery platform that can be used throughout the pharmaceutical industry. The technology promises to speed the development of new treatments for a whole range of diseases, in some cases from years to weeks. The company already has partnerships with big drug companies such as Merck, Roche, Pfizer, and Novartis.